This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Altintas, F. Articles by Cansever, M. S. Search for Related Content PubMed PubMed Citation Articles by Altintas, F. Articles by Cansever, M. S. Related Collections Complications Regional Anesthesia Pharmacology

---

REGIONAL ANESTHESIA

Interscalene Brachial Plexus Block with Bupivacaine and Ropivacaine in Patients with Chronic Renal Failure: Diaphragmatic Excursion and Pulmonary Function Changes

Fatis Altintas, MD^*, Funda Gumus, MD^*, Guner Kaya, MD^*, Ismail Mihmanli, MD, Fatih Kantarci, MD, Kamil Kaynak, MD, and M. Serif Cansever, MSc

Departments of *Anesthesiology, Radiology, Thoracic Surgery, and Pediatrics, Metabolism Division Laboratory, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey

Address correspondence and reprint requests to Fatis Altintas, MD, Nispetiye Cad Prof Sitesi A-2 Blok D 9, Etiler, Istanbul, Turkey. Address e-mail to fatisaltintas{at}hotmail.com.

In this randomized, double-blind study, we compared the anesthetic characteristics and pulmonary function changes of 0.33% bupivacaine and 0.33% ropivacaine used for interscalene brachial plexus (IBP) anesthesia in patients with chronic renal failure. Forty-two patients undergoing IBP anesthesia for creation of arteriovenous fistulas were randomly allocated to receive either 30 mL of 0.33% bupivacaine (Group B) or 0.33% ropivacaine (Group R). Block onset time, diaphragmatic excursion (ultrasonographic evaluation), and free plasma concentrations of bupivacaine and ropivacaine were evaluated. Negative motion or immobility of the ipsilateral hemidiaphragm and a decrease of >10 mm in positive motion were defined as diaphragmatic paresis. The pulmonary function variables were measured by bedside spirometry equipment. Seven patients needed supplemental local anesthetic, one with total spinal block; these patients were excluded from the study. The success rate was 80.9%. Block quality was similar in the two groups. Ipsilateral hemidiaphragmatic excursion was decreased in both groups compared with baseline values (P < 0.05). Diaphragmatic paresis was identified in 10 of 16 patients and 8 of 18 patients in Groups B and R, respectively (P > 0.05). Pulmonary function significantly decreased from baseline in both groups (forced vital capacity (FVC) 30%, forced expiratory volume at 1 second (FEV₁) 32%, and peak expiratory flow (PEF) 31% in Group B and FVC 17%, FEV₁ 17%, and PEF 5% in Group R) (P < 0.001). The decreases in Group B were larger than those in Group R (P < 0.05). Three patients in Group B and one in Group R had mild respiratory problems (P > 0.05). Concentrations of bupivacaine and ropivacaine were below toxic levels rather than "normal range." We conclude that pulmonary function decreased more after IBP with 0.33% bupivacaine than with 0.33% ropivacaine.

This article has been cited by other articles:

				F. Altintas Is the Interscalene Brachial Plexus Block the Best Approach? Anesth. Analg., February 1, 2006; 102(2): 653 - 653. [Full Text] [PDF]

				S. Blumenthal, H. Jutzi, and A. Borgeat Is the Interscalene Brachial Plexus Block the Best Approach? Anesth. Analg., February 1, 2006; 102(2): 652 - 653. [Full Text] [PDF]